1,996
Views
108
CrossRef citations to date
0
Altmetric
Original Articles

Aspartate decarboxylase (PanD) as a new target of pyrazinamide in Mycobacterium tuberculosis

, , , , , , & show all
Pages 1-8 | Received 23 Sep 2015, Accepted 02 Nov 2015, Published online: 25 Jan 2019

  • Zhang Y, Chang K, Leung C et al.“ZS-MDR-TB” versus “ZR-MDR-TB”: Improving Treatment of MDR-TB by Identifying Pyrazinamide Susceptibility. Emerg Microbes Infect2012;1: e5.
  • World Health Organization. Treatment of tuberculosis: guidelines, Fourth edition.Geneva: WHO, 2010.Available at http://www.who.int/tb/publications/2010/9789241547833/en/ (accessed 28 June 2014).
  • Zhang Y, Shi W, Zhang W, Denis Mitchison.Mechanisms of Pyrazinamide Action and Resistance. Microbiol Spectrum2014;2: 2.4.03.
  • Zhang Y, Mitchison D.The curious characteristics of pyrazinamide: a review. Int J Tuberc Lung Dis2003;7: 6–21.
  • Scorpio A, Zhang Y.Mutations in pncA, a gene encoding pyrazinamidase/nicotinamidase, cause resistance to the antituberculous drug pyrazinamide in tubercle bacillus. Nat Med1996;2: 662–667.
  • Scorpio A, Lindholm-Levy P, Heifets L et al.Characterization of pncA mutations in pyrazinamide-resistant Mycobacterium tuberculosis. Antimicrob Agents Chemother1997;41: 540–543.
  • Shi W, Zhang X, Jiang X et al.Pyrazinamide inhibits trans-translation in Mycobacterium tuberculosis. Science2011;333: 1630–1632.
  • Tan Y, Hu Z, Zhang T et al.Role of pncA and rpsA gene sequencing in detection of pyrazinamide resistance in Mycobacterium tuberculosis isolates from southern China. J Clin Microbiol2014;52: 291–297.
  • Simons SO, Mulder A, van Ingen J, Boeree MJ, van Soolingen D.Role of rpsA gene sequencing in diagnosis of pyrazinamide resistance. J Clin Microbiol2013;51: 382.
  • Feuerriegel S, Koser CU, Richter E, Niemann S.Mycobacterium canettii is intrinsically resistant to both pyrazinamide and pyrazinoic acid. J Antimicrob Chemother2013;68: 1439–1440.
  • Alexander DC, Ma JH, Guthrie JL, Blair J, Chedore P, Jamieson FB.Gene sequencing for routine verification of pyrazinamide resistance in Mycobacterium tuberculosis: a role for pncA but not rpsA. J Clin Microbiol2012;50: 3726–3728.
  • Zhang S, Chen J, Shi W, Liu W, Zhang WH, Zhang Y.Mutations in panD encoding aspartate decarboxylase are associated with pyrazinamide resistance in Mycobacterium tuberculosis. Emerg Microbes Infect2013;2: e34.
  • Zheng H, Lu L, Wang B et al.Genetic basis of virulence attenuation revealed by comparative genomic analysis of Mycobacterium tuberculosis strain H37Ra versus H37Rv. PLoS One2008;3: e2375.
  • Ehrt S, Guo XV, Hickey CM et al.Controlling gene expression in mycobacteria with anhydrotetracycline and Tet repressor. Nucleic Acids Res2005;33: e21.
  • Zhang Y, Garbe T, Young D.Transformation with katG restores isoniazid-sensitivity in Mycobacterium tuberculosis isolates resistant to a range of drug concentrations. Mol Microbiol1993;8: 521–524.
  • Zhang Y, Permar S, Sun Z.Conditions that may affect the results of susceptibility testing of Mycobacterium tuberculosis to pyrazinamide. J Med Microbiol2002;51: 42–49.
  • Chopra S, Pai H, Ranganathan A.Expression, purification, and biochemical characterization of Mycobacterium tuberculosis aspartate decarboxylase, PanD. Protein Expr Purif2002;25: 533–540.
  • Zhang Y, Scorpio A, Nikaido H, Sun Z.Role of acid pH and deficient efflux of pyrazinoic acid in unique susceptibility of Mycobacterium tuberculosis to pyrazinamide. J Bacteriol1999;181: 2044–2049.
  • Gopalan G, Chopra S, Ranganathan A, Swaminathan K.Crystal structure of uncleaved L-aspartate-alpha-decarboxylase from Mycobacterium tuberculosis. Proteins2006;65: 796–802.
  • Zhang Y, Yew WW, Barer MR.Targeting persisters for tuberculosis control. Antimicrob Agents Chemother2012;56: 2223–2230.
  • Sizemore C, Schleif AC, Bernstein JB, Heilman CA.The role of biomedical research in global tuberculosis control: gaps and challenges. Emerg Microbes Infect2012;1: e9.
  • Zhang Y.Persisters, Persistent Infections and the Yin-Yang Model. Emerg Microbes Infect2014;3: e3.
  • Zhang Y, Wade MM, Scorpio A, Zhang H, Sun Z.Mode of action of pyrazinamide: disruption of Mycobacterium tuberculosis membrane transport and energetics by pyrazinoic acid. J Antimicrob Chemother2003;52: 790–795.
  • Darby CM, Ingolfsson HI, Jiang X et al.Whole cell screen for inhibitors of pH homeostasis in Mycobacterium tuberculosis. PLoS One2013;8: e68942.
  • Sambandamurthy VK, Wang X, Chen B et al.A pantothenate auxotroph of Mycobacterium tuberculosis is highly attenuated and protects mice against tuberculosis. Nat Med2002;8: 1171–1174.
  • Sharma R, Kothapalli R, Van Dongen AM, Swaminathan K.Chemoinformatic identification of novel inhibitors against Mycobacterium tuberculosis L-aspartate alpha-decarboxylase. PLoS One2012;7: e33521.
  • White EL, Southworth K, Ross L et al.A novel inhibitor of Mycobacterium tuberculosis pantothenate synthetase. J Biomol Screen2007;12: 100–105.
  • Kumar A, Casey A, Odingo J et al.A high-throughput screen against pantothenate synthetase (PanC) identifies 3-biphenyl-4-cyanopyrrole-2-carboxylic acids as a new class of inhibitor with activity against Mycobacterium tuberculosis. PLoS One2013;8: e72786.